India to Turkmenistan Pharmaceutical Export (2026) — $36.5M, 154 Suppliers | TransData Nexus

India to Turkmenistan Pharmaceutical Export (2026) — $36.5M, 154 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Turkmenistan

#	Formulation	Value	Share
1	Pharmaceutical Medicine Products, Diclof	$6.7M	18.4%
2	Pharmaceutical Medicine Products, Sildin	$1.5M	4.1%
3	Dtp-hepb-hib (pentavalent Vaccine) Dtp-hepb-hib (pentavalent Vaccine) Fully Liq…	$388.2K	1.1%
4	Pharmaceutical Medicine Products Diclofe	$344.8K	0.9%
5	Bilargen De Each Uncoated Tablet Contains Acetaminophen 300mg B N 025114 to 025…	$255.9K	0.7%
6	Carbo Spal 450 (b.no.23kcb01,2,3 M:11/23,e:10/25)vls	$252.8K	0.7%
7	Bilargen De+ Each Tablet Contains:acetaminophen 300mg B. No. 025101to 025107 Mf…	$233.6K	0.6%
8	Doxorubicin Hcl Liposome Injection, 2mg/ml, 25ml Vial Each Vial Contains Doxoru…	$200.0K	0.5%
9	Ak-baralgin Tablets No 100 ( Mm)	$199.3K	0.5%
10	Bovepar R Tablets	$188.3K	0.5%
11	Pharma Products: Cefoboost Ceftriaxon 1gm Vial with Wfi Batch No.adce23440,adce…	$155.8K	0.4%
12	Pentalgin Tablets (paracetamol+naproxen+ Caffeine+drotaverine+ Chlorpheniramine…	$142.8K	0.4%
13	H.l.medicine Carbamazepine Tabletsbp 200 Mg,no. 1000	$142.6K	0.4%
14	Pharmaceutical Medicine Products Combipa	$140.3K	0.4%
15	Dimethyl Fumarate Delayed Release Capsules 240mg (372 Packx60=22320 Capsules)	$132.2K	0.4%

India exports 20+ pharmaceutical formulations to Turkmenistan with a combined trade value of $36.5M. Key products include Carboplatin ($253K), Doxorubicin ($200K), Paracetamol ($143K), Formoterol ($120K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 2,779 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Turkmenistan Trade Routes

1Carboplatin$253K

2Doxorubicin$200K

3Paracetamol$143K

4Formoterol$120K

These are the top pharmaceutical products exported from India to Turkmenistan, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Turkmenistan buyers, regulatory requirements, and logistics for that specific product corridor. Products include Carboplatin ($253K), Doxorubicin ($200K), Paracetamol ($143K), Formoterol ($120K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to Turkmenistan

1Antila Lifesciences Private Limited

$8.7M

2Glow Pharma Private Limited

$2.4M

3Akriti Pharmaceuticals Private Limited

$2.2M

4God Gift Laboratory Private Limited

$1.0M

5Oxford Laboratories Private Limited

Port Analysis — India to Turkmenistan Pharmaceutical Shipments

Indian Export Ports

NHAVA SHEVA SEA (INNSA1)30.8%

AHEMDABAD ICD5.1%

JNPT10.4%

JNPT/ NHAVA SHEVA SEA11.3%

SAHAR AIR CARGO ACC (INBOM4)3.2%

Turkmenistan Import Ports

Ashkhabad49.9%

ASHKHABAD34.7%

Bandar Abbas1.6%

Turkmanbashi3.7%

TURKMANBASHI2.1%

Trade Statistics

Total Value$36.5M

Shipments2,779

Indian Exporters154

Turkmenistan Buyers201

Avg Shipment$13K

Products1,988

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B

Last updated: March 28, 2026

India–Turkmenistan Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and Turkmenistan has experienced significant growth over the past two decades. In 2000, India's pharmaceutical exports to Turkmenistan were valued at approximately $7 million. By 2024, this figure had increased to $27.37 million, reflecting a substantial expansion in bilateral trade. This upward trajectory underscores the strengthening economic ties and the growing demand for Indian pharmaceutical products in Turkmenistan.

Key milestones in this trade relationship include the establishment of the joint venture 'Turkmen Derman Ajanta Pharma Ltd' in Ashgabat in 1998, with Ajanta Pharma Ltd. as the technical partner. This venture has been instrumental in providing the Turkmen market with affordable medical products. Additionally, the formation of the India–Central Asia Business Council (ICABC) in February 2020 has further facilitated trade and economic cooperation between India and Turkmenistan.

2India's Market Position

India holds a dominant position in Turkmenistan's pharmaceutical import market. In 2024, India's pharmaceutical exports to Turkmenistan were valued at $27.37 million, making it the largest supplier of pharmaceutical products to Turkmenistan. This substantial share highlights India's strategic importance as a key partner in meeting Turkmenistan's healthcare needs.

Recent Developments

Turkmenistan Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to export products to Turkmenistan must adhere to the regulations set by the National Drug Regulatory Authority, which requires compliance with WHO-GMP standards. The registration process involves submitting a comprehensive dossier, typically in the Common Technical Document (CTD) or electronic Common Technical Document (eCTD) format, which includes detailed information on the product's quality, safety, and efficacy. Bioequivalence studies may be required to demonstrate that the product performs similarly to the reference product. The timeline for registration can vary, but it generally involves thorough evaluation by Turkmenistan's regulatory authorities.

2GMP & Facility Requirements

Turkmenistan mandates that pharmaceutical products imported into the country be manufactured in facilities that comply with WHO-GMP standards. This ensures that the products meet international quality and safety benchmarks. The inspection process involves a detailed assessment of the manufacturing facility's compliance with these standards. While Turkmenistan recognizes WHO-GMP certifications, it may also conduct its own inspections to verify compliance. Mutual recognition agreements between Turkmenistan and other countries can facilitate the acceptance of GMP certifications, streamlining the export process for Indian manufacturers.

3Import Documentation

To import pharmaceutical products into Turkmenistan, Indian exporters must provide several key documents:

Certificate of Pharmaceutical Product (CPP): Confirms that the product is authorized for sale in the exporting country.

Certificate of Analysis (CoA): Details the product's composition and quality control measures.

GMP Certificate: Verifies that the manufacturing facility adheres to Good Manufacturing Practices.

These documents are essential for customs clearance and regulatory approval. The import process involves customs procedures that ensure compliance with Turkmenistan's regulations, including potential inspections and assessments by the National Drug Regulatory Authority.

EXPORT_TRENDS

TransData Nexus Research · Turkmenistan regulatory databasesMar 2026

FAQ — India to Turkmenistan Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Turkmenistan?

India exported pharmaceuticals worth $36.5M to Turkmenistan across 2,779 verified shipments.

Who are the top Indian pharmaceutical exporters to Turkmenistan?

1. ANTILA LIFESCIENCES PRIVATE LIMITED — $8.7M. 2. GLOW PHARMA PRIVATE LIMITED — $2.4M. 3. AKRITI PHARMACEUTICALS PRIVATE LIMITED — $2.2M. Total: 154 suppliers.

Which companies in Turkmenistan import pharmaceuticals from India?

1. TO THE ORDER OF. — $8.2M. 2. M/S SAGLYK E.S. — $1.6M. 3. TURKMENDERMANSENAGAT ASSOCIATION — $1.1M. 201 buyers total.

What pharmaceutical products does India export most to Turkmenistan?

1. Pharmaceutical Medicine Products, Diclof ($6.7M, 18.4%); 2. Pharmaceutical Medicine Products, Sildin ($1.5M, 4.1%); 3. Dtp-hepb-hib (pentavalent Vaccine) Dtp-hepb-hib (pentavalent Vaccine) Fully Liq… ($388.2K, 1.1%); 4. Pharmaceutical Medicine Products Diclofe ($344.8K, 0.9%); 5. Bilargen De Each Uncoated Tablet Contains Acetaminophen 300mg B N 025114 to 025… ($255.9K, 0.7%)

Which ports handle pharmaceutical shipments from India to Turkmenistan?

Export: NHAVA SHEVA SEA (INNSA1), AHEMDABAD ICD, JNPT, JNPT/ NHAVA SHEVA SEA, SAHAR AIR CARGO ACC (INBOM4). Import: Ashkhabad, ASHKHABAD, Bandar Abbas, Turkmanbashi, TURKMANBASHI.

Why does Turkmenistan import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $36.5M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Turkmenistan?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Turkmenistan pharmaceutical trade?

$13.1K per consignment across 2,779 shipments.

How many Indian pharmaceutical companies export to Turkmenistan?

154 Indian companies. Largest: ANTILA LIFESCIENCES PRIVATE LIMITED with $8.7M.

How can I find verified Indian pharmaceutical suppliers for Turkmenistan?

TransData Nexus covers 154 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Turkmenistan identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 2,779 verified shipments from 154 Indian exporters to 201 Turkmenistan buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

154 Exporters

201 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Turkmenistan Pharmaceutical Export

Top Pharmaceutical Formulations — India to Turkmenistan

Top Pharmaceutical Products — India to Turkmenistan Trade Routes

Top Indian Exporters to Turkmenistan

Port Analysis — India to Turkmenistan Pharmaceutical Shipments

Indian Export Ports

Turkmenistan Import Ports

Trade Statistics

Other Destinations

India–Turkmenistan Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

Recent Developments

Top Turkmenistan Buyers from India

Product Routes

Full Dataset Access

Turkmenistan Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Turkmenistan

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Turkmenistan

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Turkmenistan Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance